- Strategists on Dubai: Avoid 'Rash Moves' Now
- Dubai Stock Market Fear Has 'Legs': Dennis Gartman
- Surprising Options Trades in TiVo Shares
- 10 Dividend Picks For Your Portfolio: Chief Investors
- 4 Thanksgiving Week Buys For Your Portfolio: Market Pros
- There's a 'Great Chance' For a Double-Dip Recession: Strategist
- Retail Earnings and Sales to Improve in Q4: Analyst
- 4 Food Stocks to Stuff in Your Portfolio: Analyst
- S&P at 1050-1200 Trading Range Next Year: Strategist
- Art Cashin: Caution 'Growing' in Financials, Dividend Moves
MOST SHARED
- 8 Retailers that Gain During the Holidays
- Dubai Fallout Is a Correction, Not Another Crisis: El-Erian
- Get Paid Six Figures to Wear a T-Shirt?
- Finding the Holiday's Best Buys
- Dubai Spooks Investors But May Bring Buying Opportunity
- Banks Play Down Dubai Exposure, Investors Still Wary
- Some of Dubai World's Major Holdings Around Globe
- Banks With The Biggest Exposure to The UAE
- San Miguel Sells $1.36 Billion Stake to Ally
- Longer Lines, Fuller Carts This Black Friday
- Dubai Stock Market Fear Has 'Legs': Dennis Gartman
- Obama's Emission Reduction Pledge Paints Future for Autos
- Is Super Bowl Halftime Act Too Old?
- Surprising Options Trades in TiVo Shares
- EA Sports Hopes to Pump Up Sales Through Pop-Up Locations
- 8 Retailers that Gain During the Holidays
- Farrell: What's Different On This Black Friday
- 10 Dividend Picks For Your Portfolio: Chief Investors
- Dubai Spooks Investors But May Bring Buying Opportunity
- Dubai Fallout Is a Correction, Not Another Crisis: El-Erian
- Dubai's Debt Woes Signal New Era for Creditors
- Longer Lines, Fuller Carts This Black Friday
- The World's Biggest Debtor Nations
- Commodities Hammered as Investors Flee to US Dollars
- Five Tips for Buying a Foreclosed Home
- Get Paid Six Figures to Wear a T-Shirt?
- Shoppers Hit Black Friday Sales; Budgets Pared
RSS FEED
CNBC Stock Blog
Text Size 
Deals may have slowed down, but M&A ain't dead.
Big mergers and acquisitions across sectors including biotech and pharma, tech, materials and manufacturing are coming to pass. And high-profile combinations including Roche and Genentech [DNA
Loading...
()
], Dow Chemical [DOW
Loading...
()
] and Rohm & Haas [ROH
Loading...
()
] are expected to close soon.
Roche finally has a sufficient war chest of "enormous amounts of capital" which it raised in the U.S. and Europe, reports CNBC's David Faber. The Swiss drug maker now holds 93.2 percent of Genentech, with 3 percent of the latter's outstanding shares "guaranteed to be delivered within three business days."
Watch the video above for Faber's full report.
_________________________________
More from CNBC:
_________________________________
_________________________________
Data is a real-time snapshot *Data is delayed at least 15 minutes